First-line ipilimumab bests placebo in trial using DTIC: Commentary

Jeffrey A. Sosman^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

TY - JOUR

T1 - First-line ipilimumab bests placebo in trial using DTIC

T2 - Commentary

AU - Sosman, Jeffrey A.

PY - 2011/7/1

Y1 - 2011/7/1

UR - http://www.scopus.com/inward/record.url?scp=80052289462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052289462&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:80052289462

SN - 1548-5323

JO - Oncology Report

JF - Oncology Report

IS - JULY-AUGUST

ER -